COCO vs. ANAB
COCO (The Vita Coco Company, Inc.) and ANAB (AnaptysBio, Inc.) are both stocks. COCO operates in Beverages - Non-Alcoholic (Consumer Defensive), while ANAB operates in Biotechnology (Healthcare). Over the past 3 years, COCO returned 42.82%/yr vs 66.32%/yr for ANAB. At a 0.14 correlation, their price movements are largely independent.
Performance
COCO vs. ANAB - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, COCO achieves a 58.50% return, which is significantly lower than ANAB's 77.94% return.
COCO
- 1D
- 0.45%
- 1M
- 10.49%
- YTD
- 58.50%
- 6M
- 57.11%
- 1Y
- 139.24%
- 3Y*
- 42.82%
- 5Y*
- —
- 10Y*
- —
ANAB
- 1D
- 1.30%
- 1M
- -3.68%
- YTD
- 77.94%
- 6M
- 75.76%
- 1Y
- 272.31%
- 3Y*
- 66.32%
- 5Y*
- 28.81%
- 10Y*
- —
COCO vs. ANAB - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
COCO The Vita Coco Company, Inc. | 58.50% | 43.62% | 43.90% | 85.60% | 23.72% | -27.33% |
ANAB AnaptysBio, Inc. | 77.94% | 266.16% | -38.19% | -30.88% | -10.82% | 21.89% |
Correlation
The correlation between COCO and ANAB is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2021 | 0.14 |
Fundamentals
COCO:
$5.08B
ANAB:
$1.65B
COCO:
$1.38
ANAB:
-$0.91
COCO:
7.67
ANAB:
7.29
COCO:
14.43
ANAB:
129.44
COCO:
$658.62M
ANAB:
$232.39M
COCO:
$246.32M
ANAB:
$245.59M
COCO:
$100.45M
ANAB:
$52.72M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
COCO vs. ANAB — Risk / Return Rank
COCO
ANAB
COCO vs. ANAB - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for The Vita Coco Company, Inc. (COCO) and AnaptysBio, Inc. (ANAB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| COCO | ANAB | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.31 | ||
| Sortino ratioReturn per unit of downside risk | -0.70 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.54 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 5.86 | 9.62 | -3.76 |
| Martin ratioReturn relative to average drawdown | 16.41 | 22.85 | -6.44 |
Loading charts...
Drawdowns
COCO vs. ANAB - Drawdown Comparison
The maximum COCO drawdown since its inception was -56.97%, smaller than the maximum ANAB drawdown of -92.08%. Use the drawdown chart below to compare losses from any high point for COCO and ANAB.
Loading charts...
Drawdown Indicators
| COCO | ANAB | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -56.97% | -92.08% | +35.11% |
Max Drawdown (1Y)Largest decline over 1 year | -23.23% | -28.15% | +4.92% |
Max Drawdown (3Y)Largest decline over 3 years | -38.55% | -69.32% | +30.77% |
Max Drawdown (5Y)Largest decline over 5 years | — | -69.32% | — |
Current DrawdownCurrent decline from peak | 0.00% | -32.89% | +32.89% |
Average DrawdownAverage peak-to-trough decline | -16.76% | -64.58% | +47.82% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.28% | 11.83% | -3.55% |
Volatility
COCO vs. ANAB - Volatility Comparison
The current volatility for The Vita Coco Company, Inc. (COCO) is 9.69%, while AnaptysBio, Inc. (ANAB) has a volatility of 12.25%. This indicates that COCO experiences smaller price fluctuations and is considered to be less risky than ANAB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| COCO | ANAB | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.69% | 12.25% | -2.56% |
Volatility (6M)Calculated over the trailing 6-month period | 41.61% | 46.71% | -5.10% |
Volatility (1Y)Calculated over the trailing 1-year period | 52.25% | 69.09% | -16.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 56.71% | 65.38% | -8.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 56.71% | 75.41% | -18.70% |
Dividends
COCO vs. ANAB - Dividend Comparison
Neither COCO nor ANAB has paid dividends to shareholders.
Financials
COCO vs. ANAB - Financials Comparison
This section allows you to compare key financial metrics between The Vita Coco Company, Inc. and AnaptysBio, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
COCO and ANAB have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ANAB has higher volatility (12.25%) compared to COCO (9.69%). In terms of maximum drawdown, COCO dropped -56.97% vs ANAB's -92.08%.
ANAB currently has the higher Sharpe Ratio (3.92 vs 2.61), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for COCO and ANAB
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer